Kirkland & Ellis represented Arrail Group Limited (HKSE: 6639), the largest dental services provider in the premium private dental service market in China by revenue, on its global offering and listing on the Hong Kong Exchanges and Clearing Limited on March 22, 2022.
Founded in 1999, Arrail operates Arrail Dental, a leading premium dental services brand, and Rytime Dental, a middle-end dental services brand. The company has served patients in approximately 7.4 million visits in the past 10 years.
Arrail’s IPO attracted a number of pre-IPO investors, including, among others, Temasek, Total Success Investment, Goldman Sachs, KPCB China Fund, Qiming Venture Partners, Hillhouse Capital, OrbiMed, CITIC Capital, Hina Group, Ward Ferry and Mirae Asset. Cornerstone investors included Abax Asian Structured Private Credit Fund, Harvest Great Bay Investment, Hudson Bay, OrbiMed and Top Vast.
The Kirkland team was led by transactional partner David Zhang and capital markets partners Mengyu Lu and Steve Lin. They were supported by capital markets associates Kelvin Li and Alice Tang and other capital markets legal professionals in the region.